Hutch News

Hutch News

Stories tagged 'Immunology'

Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers

Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology

Sept. 14, 2018 | By Jill Christensen / Fred Hutch News Service

Three Fred Hutch researchers recently were awarded a total of $1.5 million from the Andy Hill Cancer Research Endowment, a public-private partnership that supports cancer research in Washington.

View story >


Data drives life sciences boom in Seattle

Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference

March 30, 2018 | By Sabin Russell and Diane Mapes / Fred Hutch News Service

At a conference in Seattle, health researchers and entrepreneurs said partnerships are key as bioscience converges with data science and computer technology.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 3, 2017

Fred Hutch's Dr. Slobodan Beronja and colleagues published new findings that show healthy skin cells can fight off the cancerous tendencies of nearby cells that harbor cancer-causing mutations. Dr. Jeremy Roop, a postdoc conducting HIV research in the McElrath Lab and Computational biology in the Bloom Lab, has been named a Damon Runyan Fellow.

View story >


With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma

April 3, 2017 | By Susan Keown / Fred Hutch News Service

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

July 14, 2016

Dr. Matthias Stephan awarded for immunotherapy work; Dr. Melinda Miernacki gets grant; Dr. Jesse Bloom honored by American Society for Virology

View story >


The right tools for the job: taking immunotherapy to the next level

Dr. Matthias Stephan is combining the fields of immunology, bioengineering and gene therapy to harness the immune system to treat solid tumors

May 22, 2015 | By Dr. Sabrina Richards / Fred Hutch News Service

Dr. Matthias Stephan is a pioneer in the field of immunobioengineering, working where “materials science meets immunology” to create unconventional solutions to treating cancer. He is devising inventive strategies to circumvent the hurdles that prevent immunotherapy from being cost-effective, widely available and effective against many types of cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.